E2809 – Phase II, Randomized Study of MK-2206– Bicalutamide Combination in Patients with Rising PSA at High-Risk of Progression after Primary Therapy

Physician and Research Staff Educational Materials:

These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.

  • Physician Fact Sheet: schema, study objectives, eligibility criteria, and other key information about the study intended for promotional use among health care professionals.

Additional Information at ClinicalTrials.gov:

NCT01251861